[go: up one dir, main page]

FR2920311B1 - Composition solide, orodispersible et/ou dispersible, sans excipient a effet notoire et son procede de preparation - Google Patents

Composition solide, orodispersible et/ou dispersible, sans excipient a effet notoire et son procede de preparation

Info

Publication number
FR2920311B1
FR2920311B1 FR0757295A FR0757295A FR2920311B1 FR 2920311 B1 FR2920311 B1 FR 2920311B1 FR 0757295 A FR0757295 A FR 0757295A FR 0757295 A FR0757295 A FR 0757295A FR 2920311 B1 FR2920311 B1 FR 2920311B1
Authority
FR
France
Prior art keywords
orodispersible
dispersible
excipient
knowledge
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0757295A
Other languages
English (en)
Other versions
FR2920311A1 (fr
Inventor
Jerome Besse
Laurence Besse
Julien Pournin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galenix Innovations Sas
Original Assignee
Galenix Innovations Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0757295A priority Critical patent/FR2920311B1/fr
Application filed by Galenix Innovations Sas filed Critical Galenix Innovations Sas
Priority to EP08787573A priority patent/EP2185137A1/fr
Priority to CA2697893A priority patent/CA2697893A1/fr
Priority to US12/201,078 priority patent/US20090110725A1/en
Priority to PCT/EP2008/061420 priority patent/WO2009027521A1/fr
Priority to AU2008292085A priority patent/AU2008292085A1/en
Publication of FR2920311A1 publication Critical patent/FR2920311A1/fr
Application granted granted Critical
Publication of FR2920311B1 publication Critical patent/FR2920311B1/fr
Priority to US13/169,836 priority patent/US20110250272A1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0757295A 2007-08-31 2007-08-31 Composition solide, orodispersible et/ou dispersible, sans excipient a effet notoire et son procede de preparation Active FR2920311B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR0757295A FR2920311B1 (fr) 2007-08-31 2007-08-31 Composition solide, orodispersible et/ou dispersible, sans excipient a effet notoire et son procede de preparation
CA2697893A CA2697893A1 (fr) 2007-08-31 2008-08-29 Composition solide, orodispersible et/ou dispersible, sans excipient a effet notoire et son procede de preparation
US12/201,078 US20090110725A1 (en) 2007-08-31 2008-08-29 Solid, orodispersible and/or dispersible composition, without an excipient of known effect and its process of preparation
PCT/EP2008/061420 WO2009027521A1 (fr) 2007-08-31 2008-08-29 Composition solide, orodispersible et/ou dispersible, sans excipient a effet notoire et son procede de preparation
EP08787573A EP2185137A1 (fr) 2007-08-31 2008-08-29 Composition solide, orodispersible et/ou dispersible, sans excipient a effet notoire et son procede de preparation
AU2008292085A AU2008292085A1 (en) 2007-08-31 2008-08-29 Solid, orodispersible and/or dispersible composition, without an excipient of known effect and method for preparing same
US13/169,836 US20110250272A1 (en) 2007-08-31 2011-06-27 Solid, orodispersible and/or dispersible composition, without an excipient of known effect and its process of preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0757295A FR2920311B1 (fr) 2007-08-31 2007-08-31 Composition solide, orodispersible et/ou dispersible, sans excipient a effet notoire et son procede de preparation

Publications (2)

Publication Number Publication Date
FR2920311A1 FR2920311A1 (fr) 2009-03-06
FR2920311B1 true FR2920311B1 (fr) 2010-06-18

Family

ID=39706821

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0757295A Active FR2920311B1 (fr) 2007-08-31 2007-08-31 Composition solide, orodispersible et/ou dispersible, sans excipient a effet notoire et son procede de preparation

Country Status (6)

Country Link
US (2) US20090110725A1 (fr)
EP (1) EP2185137A1 (fr)
AU (1) AU2008292085A1 (fr)
CA (1) CA2697893A1 (fr)
FR (1) FR2920311B1 (fr)
WO (1) WO2009027521A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2468254A1 (fr) * 2010-12-15 2012-06-27 Hexal AG Comprimé à désintégration orale doté d'un effet de masquage du goût
CN103284969B (zh) * 2013-07-01 2015-05-27 南京正宽医药科技有限公司 一种利培酮分散片及其制备方法
SMT201800232T1 (it) 2015-06-18 2018-07-17 Mithra Pharmaceuticals S A Unita' di dosaggio orodispersibile contenente un componente di estetrolo
EP3310333B1 (fr) 2015-06-18 2020-04-29 Estetra SPRL Unité posologique orodispersible contenant un composant d'estétrol
KR102203229B1 (ko) * 2016-01-08 2021-01-14 에리슨제약(주) 용출률이 개선된 네비보롤을 포함하는 약학적 조성물
ES2983681T3 (es) * 2016-05-16 2024-10-24 Howell Foster Terapia de combinación para la disfunción sexual masculina
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
MX2023003432A (es) 2020-09-29 2023-08-04 Millicent Pharma Ltd Formulaciones orodispersables.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2679451B1 (fr) * 1991-07-22 1994-09-09 Prographarm Laboratoires Comprime multiparticulaire a delitement rapide.
US5298261A (en) * 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
FR2785538B1 (fr) * 1998-11-06 2004-04-09 Prographarm Laboratoires Comprime a delitement rapide perfectionne
US6296868B1 (en) * 1998-11-19 2001-10-02 Advanced Technology Pharmaceuticals Corporation Chewable tablets containing mannitol and aspartame
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible

Also Published As

Publication number Publication date
EP2185137A1 (fr) 2010-05-19
AU2008292085A1 (en) 2009-03-05
WO2009027521A1 (fr) 2009-03-05
US20090110725A1 (en) 2009-04-30
CA2697893A1 (fr) 2009-03-05
FR2920311A1 (fr) 2009-03-06
US20110250272A1 (en) 2011-10-13
AU2008292085A2 (en) 2010-07-29

Similar Documents

Publication Publication Date Title
FR2920311B1 (fr) Composition solide, orodispersible et/ou dispersible, sans excipient a effet notoire et son procede de preparation
FR2911866B1 (fr) Solide cristalise izm-1 et son procede de preparation.
GB0715896D0 (en) Microporous polymers, methods for the preparation thereof, and uses thereof
EP2371793A4 (fr) Procédés de préparation de 1,1-dichloro-2,3,3,3-tétrafluoropropène et de 2,3,3,3-tétrafluoropropène
IL238438A0 (en) 2,2,2-trifluoroacetophenones and a method for their preparation
PL2297073T3 (pl) Sposób wytwarzania 2, 3, 3, 3-trifluoropropenu
ZA201007526B (en) Process for the preparation of 2,3,3,3-tetrafluoropropene
ZA201007983B (en) Process for the preparation of 2,3,3,3-tetrafluoropropene
BRPI0820843A2 (pt) Sistema de monitoração de eletrocardiograma, e, método para operar o mesmo
FR2932486B1 (fr) Procede de preparation d'un polyamideimide, polyamideimide et composition comprenant ce polyamideimide.
FR2903992B1 (fr) Composition de scintillateur, article et procede associe.
FR2945756B1 (fr) Materiau solide nanocomposite a base d'hexa-et octacyanometallates, son procede de preparation et procede de fixation de polluants mineraux le mettant en oeuvre.
FI20096050A7 (fi) Menetelmä kalsiumkarbonaatin ja ksylaanin saostamiseksi, menetelmällä valmistettu tuote ja sen käyttö
WO2010003567A3 (fr) Tensio-actifs fluorés
IL212437A0 (en) Live, attentuated respiratory syncytial virus
FR2920775B1 (fr) Nouveaux composes diaminophenothiazine, leur procede de preparation et leurs utilisations.
FR2939433B1 (fr) Procede de preparation d'allophanate, allophanate et composition de faible viscosite comprenant l'allophanate
FR2925047B1 (fr) Procede de preparation de composes p-hydroxymandeliques eventuellement substitues et derives.
FR2918979B1 (fr) Solide cristallise im-16 et son procede de preparation
FR2912400B1 (fr) Materiau alveolaire hybride,procede pour sa preparation.
FR2933303B1 (fr) Substitut osseux,et procede pour sa preparation.
FR2925499B1 (fr) Maltitol granule pour compression directe et son procede de preparation
FI20055470L (fi) Menetelmä maitotuotteiden valmistamiseksi, näin saadut tuotteet ja niiden käyttö
FR2897775B1 (fr) Biomateriau, implant injectable le comprenant, son procede de preparation et ses utilisations
FR2927900B1 (fr) Procede de preparation d'alpha-aminoacetals optiquement actifs.

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20130430

RN Application for restoration

Effective date: 20130709

FC Decision of inpi director general to approve request for restoration

Effective date: 20140425

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12